| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/15/2007 | US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 02/15/2007 | US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037890 Cannabinoids |
| 02/15/2007 | US20070037884 Novel succinate salt of O-desmethyl-venlafaxine |
| 02/15/2007 | US20070037882 Remedy for cerebral neurodegenerative diseases using ppar agonist |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037848 Treatment of neurological conditions |
| 02/15/2007 | US20070037844 2-(1-Azabicyclo[2.2.2]oct-3-yl)-N-(7-bromo-1-benzothien-2-yl)acetamide hydrochloride; nicotinic receptor agonists; cognition activators; learning enhancement; nootropic agents; demetia; cholinergic agents; Alzheimer's disease; brain traumas; stroke; attention deficit disorder; schizophrenia |
| 02/15/2007 | US20070037843 Zolpidem hemitartrate |
| 02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037792 Pharmaceutical compositions |
| 02/15/2007 | US20070037784 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/15/2007 | US20070037778 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
| 02/15/2007 | US20070037773 Methods and compositions for treating flaviviruses and pestiviruses |
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 02/15/2007 | US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system |
| 02/15/2007 | US20070037222 Lineage restricted glial precursors |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070036863 Oxacarbazepine film-coated tablets |
| 02/15/2007 | US20070036860 Treatment of allergic conditions |
| 02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | DE102005038141A1 Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives |
| 02/15/2007 | DE102005037733A1 Adeninderivate Adenine derivatives |
| 02/15/2007 | DE10141651B4 Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung Transdermal therapeutic system (TTS) with the active ingredient fentanyl and process for its preparation |
| 02/15/2007 | CA2620960A1 3, nb dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
| 02/15/2007 | CA2618474A1 Compounds for treating alzheimer's disease |
| 02/15/2007 | CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | CA2618368A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | CA2618360A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2618019A1 Compounds for the treatment of alzheimer's disease |
| 02/15/2007 | CA2618013A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | CA2617557A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | CA2617532A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | CA2617225A1 Novel heterocyclic nf-kb inhibitors |
| 02/15/2007 | CA2616854A1 Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/15/2007 | CA2616659A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance |
| 02/15/2007 | CA2616451A1 Substituted benzyl derivatives as gsk-3 inhibitors |
| 02/15/2007 | CA2616020A1 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/15/2007 | CA2611674A1 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 02/15/2007 | CA2611389A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/15/2007 | CA2607226A1 Gabaergic agents to treat memory deficits |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752472A2 Chimeric amyloid beta peptides |
| 02/14/2007 | EP1752456A1 Corneal perception recovery drug containing amide compound |
| 02/14/2007 | EP1752449A1 Pharmaceutical coposition |
| 02/14/2007 | EP1752445A1 New crystalline form III of agometalin, the process for its preparation and pharmaceutical compositions containing it |
| 02/14/2007 | EP1752444A1 New crystalline form IV of agometaline, the process for making it and pharmaceutical compositions containing it |
| 02/14/2007 | EP1752443A1 New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it |
| 02/14/2007 | EP1752153A1 Composition having effect of modulating autonomic nerves and method of using the same |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751164A1 3,6-diazabicyclos[3.1.1]heptane derivatives with analgesic activity |
| 02/14/2007 | EP1751163A2 Compounds having affinity for dopamine d3 receptor and uses thereof |
| 02/14/2007 | EP1751150A2 Novel azabicyclic aryl derivatives |
| 02/14/2007 | EP1751149A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 02/14/2007 | EP1751145A1 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives |
| 02/14/2007 | EP1751144A1 Constrained himbacine analogs as thrombin receptor antagonists |
| 02/14/2007 | EP1751138A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
| 02/14/2007 | EP1751134A1 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents |
| 02/14/2007 | EP1751133A2 Compositions useful as inhibitors of rock and other protein kinases |
| 02/14/2007 | EP1751116A2 Pyrimidine compounds and use thereof |
| 02/14/2007 | EP1751111A1 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 02/14/2007 | EP1751106A1 Piperazine derivatives of alkyl oxindoles |
| 02/14/2007 | EP1751105A1 Piperazine derivatives of alkyl oxindoles |
| 02/14/2007 | EP1751103A1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 02/14/2007 | EP1751099A1 Cis pyrrolidinyl derivatives and their uses |
| 02/14/2007 | EP1751097A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 02/14/2007 | EP1751093A1 Substituted cyclohexylacetic acid derivatives |
| 02/14/2007 | EP1751087A1 Levodopa prodrugs, and compositions and uses thereof |
| 02/14/2007 | EP1750808A2 Myricitrin compounds for treating sleeping disorders |
| 02/14/2007 | EP1750772A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/14/2007 | EP1750752A2 Compounds and methods for increasing neurogenesis |
| 02/14/2007 | EP1750742A2 Methods of treating disease with random copolymers |
| 02/14/2007 | EP1750741A1 Methods of treating disease with random copolymers |
| 02/14/2007 | EP1750735A1 Use of an aloysia/verbrena/lippia triphylla/citridora for treating chronic and /or inflammatory diseases |
| 02/14/2007 | EP1750724A1 Method for improving cognitive function by co-administration of a gabab receptor antagonist and an acetylcholinesterase inhibitor |
| 02/14/2007 | EP1750710A1 Neuroprotective properties of dextrorotatory morphinans |
| 02/14/2007 | EP1750705A1 Selective serotonin receptor inverse agonists as therapeutics for disease |
| 02/14/2007 | EP1750692A2 Method of tonic treatment with oxyphenbutazone derivatives |
| 02/14/2007 | EP1750689A1 Treating seizures using ice inhibitors |
| 02/14/2007 | EP1750686A1 Treatment of apoptosis |
| 02/14/2007 | EP1750669A1 Solid pharmaceutical form comprising an ltb4 antagonist |
| 02/14/2007 | EP1687013B1 Drug, comprising prunus armenica, cocos nucifera and humulus lupulus |
| 02/14/2007 | EP1628662B1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| 02/14/2007 | EP1625400B1 Method for selecting allosteric regulators of class iii g protein-coupled receptors |
| 02/14/2007 | EP1615644B1 Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists with antidepressant and anxiolytic activity |
| 02/14/2007 | EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands |